Originally published by our sister publication Infectious Disease Special Edition
By Landon Gray
With concerns of resistance and increased potential for poor outcomes, the benefit of fluoroquinolone prophylaxis for neutropenia has been in question for some time.
Pros and cons were discussed in a recent debate hosted by Connect with the University of Pittsburgh Medical Center and Michigan Medicine and MAD-ID (Making a Difference in Infectious Diseases).
In the early era of chemotherapy,